ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Feb 07, 2020 21:00 JST
Source:
FUZAMEI
FUZAMEI Launches '33 Charity' Blockchain Tracing Platform
HANGZHOU, CHINA, Feb 07, 2020 - (ACN Newswire) - Hangzhou FUZAMEI has launched '33 Charity', a shared blockchain platform for tracing information, registration and storage. The Company has also donated RMB 40,000 and purchased RMB 60,000 in medical materials for Hubei charity organizations, responding to the present epidemic.
As a blockchain innovater, FUZAMEI believes that transparent and open blockchain technology is the key to solving problems in the social trust system. Therefore, it has created shared blockchain system '33 Charity' Tracing Platform, to be used for information release, registration and storage.
'33 Charity' Tracing Platform aims to coordinate various parties including charitable organizations by adopting blockchain technology to improve the efficiency of charitable cooperation, increase the transparency and credibility of charity, and contribute to improving the social trust.
'33 Charity' Tracing Platform, Reshaping Social Trust System
With '33 Charity', donors and donees can issue demands on the chain in their own names. For example, hospitals can apply for CA certificates through identity authentication agencies to obtain signatures, so that donors can know the needs of the hospitals and avoid mistakes. At the same time, CA certificates can also be matched with various suppliers and logistics parties, making the whole donation process open.
Users register donor and volunteer data independently or according to authoritative announcement sources on the '33 Charity' Tracing Platform. '33 Charity' Tracing Platform allows each enterprise or individual to socialize their donations through the blockchain. It makes charity behavior open in the public, reshapes the social trust system and allows the spirit of charity to be passed along: the first step towards charity transparency.
FUZAMEI holds that the charity platform will also become an important tool for personal credit investigation in the future, such as citizen contributions, volunteer credits, blood donation certificates and other scenes, all of which can be mapped in the blockchain.
About Hangzhou FUZAMEI Technology Co.
FUZAMEI builds "blockchain+" applications in the fields of people's livelihoods: public welfare, social assistance, education, employment, pension, precise poverty alleviation, medical and health care, commodity anti-counterfeiting and food safety. For more information, please visit www.33.cn.
Media contact:
Hangzhou FUZAMEI Technology Co.
Contact: Edwin
Email:
support@33.cn
Website:
https://www.33.cn
Source: FUZAMEI
Sectors: Daily News, Crypto, Exchange, Blockchain Technology, Local Biz
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes
Dec 08, 2025 16:34 JST
MHIET U.S. Subsidiary's Franklin Plant Celebrates 10th Anniversary
Dec 08, 2025 16:03 JST
Lexus World Premieres Lexus LFA Concept BEV Sports Car
Dec 05, 2025 19:13 JST
TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
Dec 05, 2025 18:58 JST
TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept
Dec 05, 2025 18:24 JST
World's First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel
Dec 05, 2025 18:17 JST
Hitachi at CES 2026: Building a Harmonized Society Through Technology
Dec 04, 2025 19:40 JST
Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference
Dec 04, 2025 19:08 JST
NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration
Dec 04, 2025 18:52 JST
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025
Dec 04, 2025 18:36 JST
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
Dec 03, 2025 18:19 JST
Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks
Dec 02, 2025 22:55 JST
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 01, 2025 23:04 JST
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 01, 2025 22:43 JST
More Latest Release >>
Related Release
FUZAMEI shortlisted Influential Chain Alliances China 2019, wins Outstanding Blockchain Application at 'Link 2020 - Blockchain Salon'
January 13 2020 10:00 JST
Bityuan's blockchain, the first public chain to realize Parachain technology
December 11 2019 01:00 JST
More Press release >>